If you use Tret at night, save your GHK Lux for the morning
For answers, we turned to Terry Dubrow, MD, who has spent the last 18 months studying and testing retatrutide and other GLP-1 medications
Semaglutide, a selective GLP-1 receptor agonist, primarily acts on central appetite regulation and gastric emptying, leading to reduced caloric intake, improved satiety, and clinically meaningful reductions in glycated hemoglobin (1.31.6%) and body weight
It is also not recommended for some people with a history of pancreatitis
Dietitians trained in non-diet, intuitive eating, or HAES-aligned care won't hand you a rigid plan and send you off
A nurse manager commented: Our GLP-1 patients get their initial dose first week of therapy, not after a 2-week wait. No peer-reviewed publication documents this specific initiative (to our knowledge), but it aligns with published pilots ( [6] ) ( [7] )